Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reimer

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Advances in Hematology|January 22, 2011
Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomasPeter Reimer
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 22, 2014
[CAFRAD -- Benchmark Radiology]Peter Reimer
Cancer Management and Research|June 18, 2015
New developments in the treatment of peripheral T-cell lymphoma - role of BelinostatPeter Reimer
Radiology|April 1, 2004
Tumor-targeted MR contrast agents: hype or future hope?Peter Reimer
Journal of Hematology & Oncology|September 12, 2013
Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral T-cell lymphomaPeter Reimer, Shanta Chawla
Biologics : Targets & Therapy|August 18, 2010
Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agentPeter Reimer, Rolf Vosshenrich
European Radiology|May 24, 2003
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applicationsPeter Reimer, Thomas Balzer
Current Medicinal Chemistry|November 25, 2005
Soluble paramagnetic chelates and stabilized colloidal particle solutions of iron oxides as contrast agents for magnetic resonance imagingBernd Tombach, Peter Reimer
Clinical Lymphoma & Myeloma|April 28, 2006
The role of high-dose therapy in peripheral T-cell lymphomasPeter Reimer, Thomas Rüdiger, Martin Wilhelm
European Radiology|February 27, 2004
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applicationsPeter Reimer, Günter Schneider, Wolfgang Schima
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Advances in Hematology|January 22, 2011
Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomasPeter Reimer
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 22, 2014
[CAFRAD -- Benchmark Radiology]Peter Reimer
Cancer Management and Research|June 18, 2015
New developments in the treatment of peripheral T-cell lymphoma - role of BelinostatPeter Reimer
Radiology|April 1, 2004
Tumor-targeted MR contrast agents: hype or future hope?Peter Reimer
Journal of Hematology & Oncology|September 12, 2013
Long-term complete remission with belinostat in a patient with chemotherapy refractory peripheral T-cell lymphomaPeter Reimer, Shanta Chawla
Biologics : Targets & Therapy|August 18, 2010
Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agentPeter Reimer, Rolf Vosshenrich
European Radiology|May 24, 2003
Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applicationsPeter Reimer, Thomas Balzer
Current Medicinal Chemistry|November 25, 2005
Soluble paramagnetic chelates and stabilized colloidal particle solutions of iron oxides as contrast agents for magnetic resonance imagingBernd Tombach, Peter Reimer
Clinical Lymphoma & Myeloma|April 28, 2006
The role of high-dose therapy in peripheral T-cell lymphomasPeter Reimer, Thomas Rüdiger, Martin Wilhelm
European Radiology|February 27, 2004
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applicationsPeter Reimer, Günter Schneider, Wolfgang Schima
Pageof 16